chrisvoncsefalvay/vaers-outcomes huggingface dataset:
it's like I have arthritis in this arm. It's not just a general arm pain, it's a little more than that; Pain on her right arm still ongoing; Pain while vaccine administration; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (it's like I have arthritis in this arm. It's not just a general arm pain, it's a little more than that) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced ARTHRITIS (it's like I have arthritis in this arm. It's not just a general arm pain, it's a little more than that) (seriousness criterion medically significant), PAIN IN EXTREMITY (Pain on her right arm still ongoing) and VACCINATION SITE PAIN (Pain while vaccine administration). At the time of the report, ARTHRITIS (it's like I have arthritis in this arm. It's not just a general arm pain, it's a little more than that) and PAIN IN EXTREMITY (Pain on her right arm still ongoing) had not resolved and VACCINATION SITE PAIN (Pain while vaccine administration) outcome was unknown.            Patient reports no concomitant medications. No treatment medications were reported. Patient's physician stated an MRI is necessary if patient's pain continues.  Action taken with mRNA-1273 in response to the events was not Applicable.  Company comment:Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: New event: Pain while vaccine administration was added; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Approximately 10 min after receiving her 2nd dose of Pfizer COVID vaccine pt stated that she felt like she had pressure on her chest, throat felt tight and numb and her tongue felt swollen, P 54, SPO2 99.  Pt did not appear to be in distress. Pt was given Banophen  50mg 1 tab PO with apple juice and water. After approximately 10 min pt stated that she felt "a lot better", tightness in throat, tongue swelling and chest pressure was resolving. Pt was with her daughter, discussed with pt and daughter that if she had the same symptoms after going home or felt SOB that she should seek emergent care. Both pt and daughter verbalized understanding.  Pt was observed for approximately 40 min and was released after symptoms resolved.
Information has been received from a lawyer concerning an 11 year old male pt who allegedly received 16 injections of thimerosal-laden vaccines between 5/6/98 and 4/12/00. On 5/6/98, the pt was vaccinated in the hospital with a 1st dose of Hep-B. On 5/12/99, the pt was vaccinated, IM, in the left thigh with MMRII and a dose, in the left thigh of varicella virus vaccine. It is alleged that prior to completing the schedule of vaccinations, the pt developed normally and demonstrated social language, cognitive, behavioral and physical skills appropriate for his age. Beginning in approx. 9/99, he began to display symptoms of neurological damage consistent with mercury poisoning including losing his language skills, engaging in repetitive and stereotypical behaviors, suffering from diminished cognitive ability and becoming socially withdrawn. It is also alleged that the pt has been dx'd as suffering from mercury poisoning and disintegrative (or "late onset", "degenerative" or "regressive") autism. The pt is receiving medical treatment to remove mercury from his body. As the mercury levels in his body have decreased, he has noted some improvement in his symptoms. Upon internal review, disintegrative autism was determined to be an "Other Important Medical Event". No further information is available.
Child had a fever of 101 F and over 100 chickenpox like spots all over body that blistered, dried and crusted. Spots lasted a couple days according to the mother. This all happened 2 weeks post vaccination.
Brought a really heavy period; wake up hot for six weeks; Shortened my menstrual cycle,had an earlier period, came six days earlier; Chest pains; Headache; Being tired; Cold after vaccine; Pain; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (Brought a really heavy period), FEELING HOT (wake up hot for six weeks), POLYMENORRHOEA (Shortened my menstrual cycle,had an earlier period, came six days earlier), NASOPHARYNGITIS (Cold after vaccine) and PAIN (Pain) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C11A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold after vaccine), PAIN (Pain), HEADACHE (Headache) and FATIGUE (Being tired). On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (Brought a really heavy period), FEELING HOT (wake up hot for six weeks), POLYMENORRHOEA (Shortened my menstrual cycle,had an earlier period, came six days earlier) and CHEST PAIN (Chest pains). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEAVY MENSTRUAL BLEEDING (Brought a really heavy period), FEELING HOT (wake up hot for six weeks), POLYMENORRHOEA (Shortened my menstrual cycle,had an earlier period, came six days earlier), NASOPHARYNGITIS (Cold after vaccine), PAIN (Pain), CHEST PAIN (Chest pains), HEADACHE (Headache) and FATIGUE (Being tired) outcome was unknown.            Concomitant medications reported as none.   This case was linked to US-MODERNATX, INC.-MOD-2021-149251, US-MODERNATX, INC.-MOD-2021-148821, US-MODERNATX, INC.-MOD-2021-149413, US-MODERNATX, INC.-MOD-2021-149360 (E2B Linked Report). This case was linked to MOD-2021-148424 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Added event - chest pain.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-149413:Cluster case-2nd dose US-MODERNATX, INC.-MOD-2021-149360:Cluster case-1st dose US-MODERNATX, INC.-MOD-2021-148821:Unknown female-1st dose US-MODERNATX, INC.-MOD-2021-149251:Unknown female-2nd dose
no energy; feeling terrible; fever; tired; This spontaneous case was reported by an other caregiver and describes the occurrence of ASTHENIA (no energy), MALAISE (feeling terrible), PYREXIA (fever) and FATIGUE (tired) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Feb-2021, the patient experienced ASTHENIA (no energy), MALAISE (feeling terrible), PYREXIA (fever) and FATIGUE (tired). At the time of the report, ASTHENIA (no energy), MALAISE (feeling terrible), PYREXIA (fever) and FATIGUE (tired) outcome was unknown.
sudden onset tinnitus and deafness in right ear, lasting 12 hours, resolving spontaneously.
PATIENT ADMITTED TO HOSPITAL ON 6/25/21 DUE TO RESP DISTRESS. COVID TESTING POSITIVE. DIAGNOSED WITH COVID PNEUMONIA. ON 6/25/21 NAD 6/26/21. PATIENT DIED ON 7/8/2021.
Immediately after receiving shots, patient stood up, said he did not feel well, and passed out.  He experienced whole body rigidity, eyes briefly rolled in the back of his head.  Within 1 minute he was conscious again, crying.  No subsequent weakness.  Mom states that he went home and slept for 2 hours. Unknown if patient had flu shot within a month receiving these vaccines.
COVID; COVID; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 54-year-old female patient received BNT162b2 (BNT162B2), on 04Jan2021 as dose 1, single (Lot number: FK9231), on 22Jan2021 as dose 2, single (Lot number: LL3249) and on 01Oct2021 as dose 3 (booster), single (Lot number: FF8841) at the age of 53 years for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: NYQUIL. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 2022, outcome "unknown", COVID-19 (medically significant) with onset 2022, outcome "recovered" and all described as "COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: Nasal swab. Therapeutic measures were taken as a result of covid-19. Clinical Course: Product Information: Paxlovid on 18Apr2022 to 22Apr2022; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to the drug ineffective (LOE) cannot be ruled out.
Right arm swelling, redness, pain, warm to touch, 2 days post injection of 3rd dose Anthrax. Given Zyrtec 10 mg for Tx.
(R) arm swollen from elbow to shoulder---approx. 50% larger than normal.  The swelling continued for 5 days.  There was also itching today (11/10/05).
This case was reported by a physician and described the occurrence of fever in a 37-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). On 12 May 2010 at 12:00 the subject received 1st dose of HAVRIX (1 ml, unknown route, left arm). On 14 May 2010, 2 days after vaccination with HAVRIX, the subject experienced fever, chills, low back pain, arthralgia and myalgia. He also experienced elevated alanine aminotransferase (ALT) and elevated aspartate aminotransferase (AST). The physician considered the events were disabling. Relevant test results included: baseline labs, ALT (61, units not provided) and AST (24, units not provided) levels on 12 May 2010 were normal. On an unspecified date, ALT increased to 118 (normal range 30-65) and AST increased to 79 (normal range 15-37). At the time of reporting the events were unresolved. The vaccination course with HAVRIX was discontinued. It was reported that due to the events, the subject did not wish to have any other vaccinations.
Patient noticed increase SOB around 7/7/22 with progressive cough. Patient has COPD and felt this was worse than his typical COPD per ER note. Chills and fever over the weekend. Patient presented to ER on 7/14/22. Patient prescribed Paxlovid for an at home positive test on 7/11/22. Home test was from 7/8. Admitted on 7/14/22 for Possible COVID 19 Pneumonia on both lungs, acute on chronic hypoxic respiratory failure, chronic diastolic heart failure, COPD, H/O dumping syndrome.
itching; rash; A spontaneous report  was received from a consumer concerning a 83-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash, itching/pruritus.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 12 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 015M20A) via unknown route in the right arm for prophylaxis of COVID-19 infection.  On 21 Feb 2021, the patient experienced the event(s) rash, itching.  Treatment details included Cortisone cream.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), rash, itching was unknown.
Employee is a Contractor who works at Dental Clinic. She reports itching began15 minutes after injection but did not report. States noticed tenderness/soreness to Left arm injection site @ 1830. States awakened following day, 27 October, with puffy face, rash in face, itching, groggy and fatigue. She then went to work and was took Ibuprofen 800 mg. Arrived to Occupational Health Clinic 27 October with flat red areas on forehead, cheeks and around mouth. Reports feeling tired. Also, very emotional due to recent passing of her grandmother.
Developed painful head pain/neck pain on 2/15/21, followed by red rash, on neck upper right back and upper right chest. Went to Hospital on 2/20/21. Diagnosed with Shingles by doctor at that visit, 2/20/21.
Administration of vaccine past 42 day window; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Administration of vaccine past 42 day window) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Administration of vaccine past 42 day window). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Administration of vaccine past 42 day window) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Severe joint pain involving all joint. Ligament and nerve dysfunction. x 4 weeks. Now on prednisone oral.
Became Drowsy, feeling warm, fever started. Noted to have angioedema in right upper thigh.
Mom called office this morning and said, patient's right arm was swollen, red and hot to the touch. Also has a fever. These symptoms started the day that the vaccines were given. I requested for her to bring patient into the office for Dr. to see him. Area of redness was measured 10cm.X12cm. by Dr.
Headache/cold and hot spells/ hot flashes are far worse than ever before. Body aches, face, ears, neck aches. Arm and into hand tingling. Right side of chest felt heavy. NO Fever, NO rash, NO difficulty breathing or NO true chest pain. Very weak & tired. This started about 2 hours after administer. As of now (10:17am on 3/11/2021), I am still tired and have slight cold chills/hot flashes, headache, jaw/ear sensitivity. Legs feel a bit heavy. NO fever or anything major.
48 hours after dose, became very short of breath, typically a frequent walker but was too short of breath to finish 1/8th of a mile. Lightheaded, needed to sit to catch breath. Assumed it was just fatigue after the third dose, went home and rested. Continued to worsen, went to appointment with asthma allergy doc to check PST (were fine), but doctor thought that it may have been a cardiac event. Told to go to ER by allergy doc, went to the ER, did cardiac testing found enlarged pulmonary artery on chest CT, round plast opacity. Chest x-ray similar to covid symptoms, did an SO, Stress Test, could not pass stress test because of shortness of breath. Lexi scan, heart withstood stress test despite the pulmonary issues. Discharged and had an appointment with pulmonologist scheduled (about a month out), waiting on heart cast result from out-patient two weeks ago. Called PCM for referral to pulmonologist to hopefully get an appointment sooner. Diagnosed with hypertension, given beta blocker (fistolic) 5mg, changed asthma meds from trelogy to dulera. While in hospital, given luminox and increased aspirin to adult doses.
Reaction during early morning; This is a spontaneous report from a contactable other healthcare professional. A 75-years-old female patient received second bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EJ1686) via intramuscular, in Arm Left on 09Feb2021 14:40 as single dose for covid-19 immunisation. The patient vaccine history included received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EH9899) via intramuscular, in Arm Left on 21Dec2020 for Prevent covid infection. The patient medical history and concomitant medication(s) included rivaroxaban (XARELTO); benazepril (BENAZEPRIL); diltiazem (DILTIAZEM); estrogen; testosterone (ESTROGEN; TESTOSTERONE) ta; paracetamol (TYLENOL) from 10Feb2021 14:00. The patient experienced reaction during early morning on 10Feb2021. The outcome of the events was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
10/03/2016 at 3:40 PM - Cellulitis of right upper extremity.  Prescribed Cephalexin 500 mg.  Take 1 capsule by mouth 3 x per day for 10 days.
Pt recvd vax 5NOV92 & following inject pt exp flu-like sx, severe body aches, a h/a, & nausea; sx persisted for 24 hrs; No further details were provided;
pt recvd vax;had leg soreness & 5-6 red bumps on neck w/ progressed typical varicella rash 400-500 spots;had minimal fever & mild itching;resolved p/ 8-9 days;
pt recvd vax & 2 days post vax pt devel an eczema-like rash;
Once patient got down from the exam bed, patient's equilibrium was completely off sending her straight into a door jamb.  She then fell to the ground of the clinic and passed out for a few seconds.  Became very pale and stayed extremely dizzy.  Blood pressure was good, but heart rate was only 58 beats per minute.  911 was called and the paramedics did a heart monitor test on her, which was normal.  Once the dizziness passed (about 30 minutes), she was able to walk on her own, but was weak, felt sick and had no energy for most of the rest of the day.
After 30 minutes, as I drove away, (and while chatting on the phone) I first had a metallic taste in my mouth then felt  my throat start to squeeze.  I drove back to vaccination site and they called the ambulance which did not arrive for a long time.  After 30 minutes, and after being monitored by paramedics, it got better and I left.  There was pain at the injection site for a day.
I had arm soreness, lymph node enlargement and pain, fever headaches, body aches, nausea, vomiting, diarrhea, hip pain, dizziness, fatigue. Within 24 hours I felt better.
The client alerted that he developed sharp pressure in his chest while running the day after he received his 1st COVID vaccine Pfizer. The client said he attempted to finish his run with the pain, but had to intermittently walk. The client stated the chest pressure resolved once he started running. The client also reported feeling drowsy to his mother when he returned home from his run. No medications were administered for the initial chest pressure. The client did not follow up with a primary care doctor regarding the initial chest pressure. The client denies any chronic conditions. The client's mother stated he currently takes vitamins and minerals on a regular basis, but denied any chronic medications. The client has a history of anaphylaxis to shellfish.
Fatigue, fever, swelling injection site chills, HEADACHES, hurting all over
devel rash over trunk then 24hr later rash extended to legs & few on face;no fever;varicella type rash;
I tested positive for COVID 12/26/2021. My primary symptoms is that I felt very time, headache, lost of taste and smell, I notice that I started feeling shortness of breath and wheezing. I couldn't clean the house or take a walk without having to stop a few times because my breath was short. It lasted for about a month. That's when I decide to go see my PCP. He did a exam and he said that since I had COVID my symptoms was from that. He prescribe me an inhaler and I am still using that. He said that if it hadn't improve then we will explore some other options.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old male patient received BNT162b2 (BNT162B2), on 05Jan2021 at 12:00 as dose 1, single (Lot number: EH9899), in right arm, on 26Jan2021 at 12:00 as dose 2, single (Lot number: EL7262), in right arm, on 01Oct2021 at 12:00 as dose 3 (booster), single (Lot number: FF8839), in right arm and on 01Apr2022 at 12:00 as dose 4 (booster), single (Lot number: FK9893) at the age of 68 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "heart attack", start date: 2010 (unspecified if ongoing); "possible slight iodine sensitivity" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE, start date: 01Jan2020; ROSUVASTATIN, start date: 01Jan2020; HYDROCHLOROTHIAZIDE, start date: 01Jan2020. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results; Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical Course: Patient received Other medication in 2weeks.Anti-viral details: product=COVID 19 Treatment, brand=Paxlovid, treatment start date=08Jul2022, treatment stop date=14Jul2022, lot number=GC9447, indication=Treatment of COVID-19.  No follow-up attempts are possible. No further information is expected.
Expired vaccine may have been administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine may have been administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine may have been administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine may have been administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. List of concomitant medication were not given. refrigerated Moderna that is 1 day past the 30 days of being refrigerated from frozen.